跳至主要内容
临床试验/ISRCTN21195635
ISRCTN21195635进行中(未招募)未知

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia): a randomised trial to assess the use of ciprofloxacin prophylaxis to prevent bacterial infection in children treated on the induction phase of the ALLTogether-1 treatment protocol

niversity College London0 个研究点目标入组 1,052 人开始时间: 2021年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
1,052

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 15/11/2023:
  • 1. Paediatric patients (1 - 17 years inclusive) with de-novo acute lymphoblastic leukaemia treated on ALLTogether-1 in the UK in the first 14 days of therapy (but ideally day 5-8)
  • 2. Written informed consent
  • Previous participant inclusion criteria:
  • 1. Paediatric patients (1 - 17 years inclusive) with de-novo acute lymphoblastic leukaemia treated on ALLTogether-1 in the UK in the first 5 days of therapy
  • 2. Written informed consent

排除标准

  • 1. Non-participants of the ALLTogether-1 trial
  • 2. Patients with Down syndrome who already receive ciprofloxacin prophylaxis
  • 3. Patients with chronic active arthritis
  • 4. Other contraindication to fluoroquinolones

研究者

发起方
niversity College London

相似试验